Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
405 | 3527 | 29.7 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
220 | 3 | CYTOMEGALOVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 50388 |
429 | 2 | CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HUMAN HERPESVIRUS 6 | 16394 |
405 | 1 | CYTOMEGALOVIRUS//VALGANCICLOVIR//PREEMPTIVE THERAPY | 3527 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS | authKW | 1120321 | 21% | 17% | 744 |
2 | VALGANCICLOVIR | authKW | 675397 | 4% | 57% | 136 |
3 | PREEMPTIVE THERAPY | authKW | 565936 | 3% | 65% | 101 |
4 | ANTIGENEMIA | authKW | 359642 | 2% | 52% | 80 |
5 | GANCICLOVIR | authKW | 343910 | 6% | 20% | 196 |
6 | CYTOMEGALOVIRUS INFECTION | authKW | 325977 | 3% | 33% | 115 |
7 | CMV | authKW | 250029 | 5% | 17% | 168 |
8 | PP65 ANTIGENEMIA | authKW | 163523 | 1% | 82% | 23 |
9 | CMV INFECTION | authKW | 138492 | 1% | 34% | 47 |
10 | TRANSPLANTATION | WoSSC | 121039 | 38% | 1% | 1357 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 121039 | 38% | 1% | 1357 |
2 | Immunology | 22115 | 38% | 0% | 1352 |
3 | Surgery | 10092 | 30% | 0% | 1045 |
4 | Infectious Diseases | 8157 | 15% | 0% | 524 |
5 | Virology | 5963 | 10% | 0% | 363 |
6 | Microbiology | 5087 | 17% | 0% | 596 |
7 | Hematology | 3574 | 10% | 0% | 366 |
8 | Urology & Nephrology | 580 | 4% | 0% | 158 |
9 | Medicine, General & Internal | 418 | 7% | 0% | 237 |
10 | Pathology | 288 | 3% | 0% | 115 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIV MED ASSOCIATES | 34623 | 0% | 100% | 4 |
2 | HEMATOL MED ONCOL SERV | 32784 | 0% | 32% | 12 |
3 | HEPATOBILIARY PANCREAT SURG HEPAT TRANSPLANT | 27697 | 0% | 80% | 4 |
4 | SPERIMENTALI RIC | 22300 | 0% | 18% | 14 |
5 | FDN INCLIVA | 19667 | 0% | 45% | 5 |
6 | TRANSPLANT INFECT DIS | 17662 | 0% | 29% | 7 |
7 | KLIN ABT ANASTHESIE INTENS MED | 17311 | 0% | 100% | 2 |
8 | MIX UNIT 5164 | 17311 | 0% | 100% | 2 |
9 | MOL VIROL PATHOL MICROBIOL | 17311 | 0% | 100% | 2 |
10 | RENAL TRANSPLANTAT NEPHROL | 17311 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSPLANTATION PROCEEDINGS | 43360 | 13% | 1% | 449 |
2 | TRANSPLANT INFECTIOUS DISEASE | 43333 | 2% | 7% | 76 |
3 | TRANSPLANTATION | 35637 | 8% | 2% | 276 |
4 | BONE MARROW TRANSPLANTATION | 19682 | 4% | 2% | 142 |
5 | JOURNAL OF CLINICAL VIROLOGY | 14834 | 2% | 2% | 76 |
6 | JOURNAL OF CLINICAL MICROBIOLOGY | 13522 | 6% | 1% | 205 |
7 | AMERICAN JOURNAL OF TRANSPLANTATION | 12439 | 2% | 2% | 83 |
8 | CLINICAL AND DIAGNOSTIC VIROLOGY | 11881 | 0% | 8% | 17 |
9 | JOURNAL OF MEDICAL VIROLOGY | 11011 | 3% | 1% | 99 |
10 | CLINICAL TRANSPLANTATION | 9157 | 2% | 2% | 63 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS | 1120321 | 21% | 17% | 744 | Search CYTOMEGALOVIRUS | Search CYTOMEGALOVIRUS |
2 | VALGANCICLOVIR | 675397 | 4% | 57% | 136 | Search VALGANCICLOVIR | Search VALGANCICLOVIR |
3 | PREEMPTIVE THERAPY | 565936 | 3% | 65% | 101 | Search PREEMPTIVE+THERAPY | Search PREEMPTIVE+THERAPY |
4 | ANTIGENEMIA | 359642 | 2% | 52% | 80 | Search ANTIGENEMIA | Search ANTIGENEMIA |
5 | GANCICLOVIR | 343910 | 6% | 20% | 196 | Search GANCICLOVIR | Search GANCICLOVIR |
6 | CYTOMEGALOVIRUS INFECTION | 325977 | 3% | 33% | 115 | Search CYTOMEGALOVIRUS+INFECTION | Search CYTOMEGALOVIRUS+INFECTION |
7 | CMV | 250029 | 5% | 17% | 168 | Search CMV | Search CMV |
8 | PP65 ANTIGENEMIA | 163523 | 1% | 82% | 23 | Search PP65+ANTIGENEMIA | Search PP65+ANTIGENEMIA |
9 | CMV INFECTION | 138492 | 1% | 34% | 47 | Search CMV+INFECTION | Search CMV+INFECTION |
10 | CYTOMEGALOVIRUS DISEASE | 119389 | 1% | 53% | 26 | Search CYTOMEGALOVIRUS+DISEASE | Search CYTOMEGALOVIRUS+DISEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KOTTON, CN , KUMAR, D , CALIENDO, AM , ASBERG, A , CHOU, SW , DANZIGER-ISAKOV, L , HUMAR, A , (2013) UPDATED INTERNATIONAL CONSENSUS GUIDELINES ON THE MANAGEMENT OF CYTOMEGALOVIRUS IN SOLID-ORGAN TRANSPLANTATION.TRANSPLANTATION. VOL. 96. ISSUE 4. P. 333-360 | 158 | 66% | 174 |
2 | SIA, IG , PATEL, R , (2000) NEW STRATEGIES FOR PREVENTION AND THERAPY OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID-ORGAN TRANSPLANT RECIPIENTS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 13. ISSUE 1. P. 83 -+ | 297 | 66% | 142 |
3 | TORRE-CISNEROS, J , AGUADO, JM , GASTON, JJ , ALMENAR, L , ALONSO, A , CANTISAN, S , CARRATALA, J , CERVERA, C , CORDERO, E , FARINAS, MC , ET AL (2016) MANAGEMENT OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS: SET/GESITRA-SEIMC/REIPI RECOMMENDATIONS.TRANSPLANTATION REVIEWS. VOL. 30. ISSUE 3. P. 119 -143 | 191 | 67% | 1 |
4 | RAZONABLE, RR , HAYDEN, RT , (2013) CLINICAL UTILITY OF VIRAL LOAD IN MANAGEMENT OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION.CLINICAL MICROBIOLOGY REVIEWS. VOL. 26. ISSUE 4. P. 703-727 | 157 | 78% | 28 |
5 | HODSON, EM , LADHANI, M , WEBSTER, AC , STRIPPOLI, GFM , CRAIG, JC , (2013) ANTIVIRAL MEDICATIONS FOR PREVENTING CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 120 | 85% | 29 |
6 | DE LA TORRE-CISNEROS, J , FARINAS, MC , CASTON, JJ , AGUADO, JM , CANTISAN, S , CARRATALA, J , CERVERA, C , CISNEROS, JM , CORDERO, E , CRESPO-LEIRO, MG , ET AL (2011) GESITRA-SEIMC/REIPI RECOMMENDATIONS FOR THE MANAGEMENT OF CYTOMEGALOVIRUS INFECTION IN SOLID-ORGAN TRANSPLANT PATIENTS.ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. VOL. 29. ISSUE 10. P. 735 -758 | 153 | 67% | 28 |
7 | BOECKH, M , BOIVIN, G , (1998) QUANTITATION OF CYTOMEGALOVIRUS: METHODOLOGIC ASPECTS AND CLINICAL APPLICATIONS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 11. ISSUE 3. P. 533-+ | 135 | 81% | 253 |
8 | OWERS, DS , WEBSTER, AC , STRIPPOLI, GFM , KABLE, K , HODSON, EM , (2013) PRE-EMPTIVE TREATMENT FOR CYTOMEGALOVIRUS VIRAEMIA TO PREVENT CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 106 | 89% | 3 |
9 | KOTTON, CN , (2013) CMV: PREVENTION, DIAGNOSIS AND THERAPY.AMERICAN JOURNAL OF TRANSPLANTATION. VOL. 13. ISSUE . P. 24-40 | 93 | 68% | 56 |
10 | RAZONABLE, RR , HUMAR, A , (2013) CYTOMEGALOVIRUS IN SOLID ORGAN TRANSPLANTATION.AMERICAN JOURNAL OF TRANSPLANTATION. VOL. 13. ISSUE . P. 93-106 | 67 | 77% | 99 |
Classes with closest relation at Level 1 |